Free energy along drug-protein binding pathways interactively sampled in virtual reality.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 10 2023
Historique:
received: 30 06 2023
accepted: 25 09 2023
medline: 2 11 2023
pubmed: 5 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

We describe a two-step approach for combining interactive molecular dynamics in virtual reality (iMD-VR) with free energy (FE) calculation to explore the dynamics of biological processes at the molecular level. We refer to this combined approach as iMD-VR-FE. Stage one involves using a state-of-the-art 'human-in-the-loop' iMD-VR framework to generate a diverse range of protein-ligand unbinding pathways, benefitting from the sophistication of human spatial and chemical intuition. Stage two involves using the iMD-VR-sampled pathways as initial guesses for defining a path-based reaction coordinate from which we can obtain a corresponding free energy profile using FE methods. To investigate the performance of the method, we apply iMD-VR-FE to investigate the unbinding of a benzamidine ligand from a trypsin protein. The binding free energy calculated using iMD-VR-FE is similar for each pathway, indicating internal consistency. Moreover, the resulting free energy profiles can distinguish energetic differences between pathways corresponding to various protein-ligand conformations (e.g., helping to identify pathways that are more favourable) and enable identification of metastable states along the pathways. The two-step iMD-VR-FE approach offers an intuitive way for researchers to test hypotheses for candidate pathways in biomolecular systems, quickly obtaining both qualitative and quantitative insight.

Identifiants

pubmed: 37794083
doi: 10.1038/s41598-023-43523-x
pii: 10.1038/s41598-023-43523-x
pmc: PMC10551034
doi:

Substances chimiques

Ligands 0
Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16665

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L018756/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M026280/1
Pays : United Kingdom

Informations de copyright

© 2023. Springer Nature Limited.

Références

J Chem Phys. 2007 Feb 7;126(5):054103
pubmed: 17302470
J Chem Theory Comput. 2015 Oct 13;11(10):5002-11
pubmed: 26574285
Protein Sci. 2020 Jan;29(1):237-246
pubmed: 31710727
J Phys Chem Lett. 2019 Jun 20;10(12):3495-3499
pubmed: 31188006
J Comput Chem. 2011 Oct;32(13):2909-23
pubmed: 21735452
J Chem Theory Comput. 2016 Jun 14;12(6):2983-9
pubmed: 27159059
J Med Chem. 2008 Nov 13;51(21):6654-64
pubmed: 18834104
J Comput Chem. 2014 Sep 5;35(23):1672-81
pubmed: 24986052
Proteins. 2004 May 1;55(2):383-94
pubmed: 15048829
J Chem Phys. 2021 Oct 21;155(15):154106
pubmed: 34686059
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
J Am Chem Soc. 2008 Oct 22;130(42):13938-44
pubmed: 18811160
J Chem Theory Comput. 2019 Nov 12;15(11):5829-5844
pubmed: 31593627
J Chem Phys. 2019 Jun 14;150(22):221101
pubmed: 31202231
J Virol. 2007 Dec;81(24):13845-51
pubmed: 17928344
Curr Opin Struct Biol. 2020 Oct;64:126-133
pubmed: 32771530
Expert Opin Drug Discov. 2022 Jul;17(7):685-698
pubmed: 35638298
Sci Adv. 2018 Jun 29;4(6):eaat2731
pubmed: 29963636
PLoS One. 2020 Mar 11;15(3):e0228461
pubmed: 32160194
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Chem Sci. 2021 Sep 6;12(41):13686-13703
pubmed: 34760153
J Chem Phys. 2019 Jun 14;150(22):220901
pubmed: 31202243
Sci Adv. 2020 Sep 2;6(36):
pubmed: 32917594
J Biol Chem. 1965 Apr;240:1579-85
pubmed: 14285494
Sci Rep. 2015 Feb 12;5:8425
pubmed: 25672826
Beilstein J Nanotechnol. 2015 Nov 16;6:2148-53
pubmed: 26665087
Nat Commun. 2015 Jul 02;6:7653
pubmed: 26134632
J Comput Chem. 2002 Dec;23(16):1623-41
pubmed: 12395429
J Phys Chem B. 2017 Apr 20;121(15):3597-3606
pubmed: 28191969
J Chem Phys. 2020 Oct 21;153(15):154105
pubmed: 33092381
J Chem Theory Comput. 2012 May 8;8(5):1795-801
pubmed: 26593670
Antiviral Res. 2003 May;58(3):235-42
pubmed: 12767471
Nat Commun. 2018 Sep 3;9(1):3559
pubmed: 30177695
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10184-9
pubmed: 21646537
J Phys Chem A. 2019 May 23;123(20):4486-4499
pubmed: 30892040
J Mol Graph Model. 2019 Jun;89:234-241
pubmed: 30921557
Sci Rep. 2021 Apr 7;11(1):7610
pubmed: 33828325
J Chem Inf Model. 2020 Dec 28;60(12):5803-5814
pubmed: 33174415
Curr Opin Struct Biol. 2017 Apr;43:141-147
pubmed: 28327454
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):E386-91
pubmed: 25605901
Drug Discov Today. 2015 Jun;20(6):686-702
pubmed: 25615716
J Chem Theory Comput. 2020 Sep 8;16(9):5526-5547
pubmed: 32692556
J Phys Chem A. 2017 Dec 28;121(51):9764-9772
pubmed: 29190105
J Chem Theory Comput. 2019 Jan 8;15(1):25-32
pubmed: 30468578

Auteurs

Helen M Deeks (HM)

Center for Computational Chemistry, School of Chemistry, University of Bristol, Bristol, BS8 1TS, UK.

Kirill Zinovjev (K)

Departamento de Química Física, Universidad de Valencia, 46100, Burjassot, Spain.
School of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK.

Jonathan Barnoud (J)

Center for Computational Chemistry, School of Chemistry, University of Bristol, Bristol, BS8 1TS, UK.
CiTIUS | Centro Singular de Investigación en Tecnoloxías Intelixentes da USC, Rúa de Jenaro de la Fuente, s/n, 15705, Santiago de Compostela, A Coruña, Spain.

Adrian J Mulholland (AJ)

Center for Computational Chemistry, School of Chemistry, University of Bristol, Bristol, BS8 1TS, UK.

Marc W van der Kamp (MW)

Center for Computational Chemistry, School of Chemistry, University of Bristol, Bristol, BS8 1TS, UK. marc.vanderkamp@bristol.ac.uk.
School of Biochemistry, University of Bristol, Bristol, BS8 1TD, UK. marc.vanderkamp@bristol.ac.uk.

David R Glowacki (DR)

CiTIUS | Centro Singular de Investigación en Tecnoloxías Intelixentes da USC, Rúa de Jenaro de la Fuente, s/n, 15705, Santiago de Compostela, A Coruña, Spain. drglowacki@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH